BEIJING and CLAREMONT, Calif., Feb. 4 /Xinhua-PRNewswire-FirstCall/ -- (OTC Bulletin Board: KWBT) Kiwa Bio-Tech Products Group Corporation's CEO and Board Chairman, Mr. Wei Li, met to discuss cooperative ventures with members of the Canadian Agricultural Ministry and Natunola Health, Inc. of Ottawa (Toronto Venture Exchange Symbol: SXS).
Among the participants in the meetings with Mr. Li was Dr. Jianqiang
Zhou who is the Chief Officer of Scientific Relations China, International
Science Cooperation Bureau of Canadian Agricultural Ministry. During the
session, Dr. Zhou introduced three main areas for cooperative development:
-- advanced technology for growing oats
-- a breeding program for promising potatoes,
-- soil nutrient measurement and development of formulas and
fertilization technology transferring experience from research being
conducted for Kiwa at China Agricultural University Mr. Zhou looks to Kiwa to bring a commercial operation focus for the above three projects in order to effectively utilize available governmental capital and support. Based on the successful government directed communication between these two countries, project implementation needs experienced commercial business companies with demonstrated strengths to join together.
Mr. Li also met with Dr. Nam Fong Han, President and CEO, of Canadian listed company, Natunola Health, Inc. (Toronto Venture Exchange Symbol: SXS) in Ottawa, to discuss working together through Canada-China Agri-Technology cooperation arrangements including possible commercial cooperation between Natunola and Kiwa in the near future. Natunola Health Inc. specializes in developing products derived from natural sources primarily for human health, personal care and animal nutritional market. Natunola Health Inc. helps the commercialization of one of Agriculture and Agri-Food Canada (AAFC) patented technologies, omega-3 flaxseed dehulling technology, and has an excellent working relationship with AAFC.
Mr. Wei Li, Chairman of the Board and CEO of the Company, stated, "Through these meetings, Kiwa has established good relations with Canadian government agencies, technology development organizations and commercial operations with the Canadian agricultural industry. This lays the groundwork for future discussions."
About Natunola Health Inc.
The Canadian company based in Ottawa, Ontario is becoming a leading supplier of botanical ingredients to the cosmetic industry as well as shelled flaxseed to the food industry.
Thanks to its patented technologies, in particular its Vegetable Gel Technology, Natunola is able to offer health conscious consumers a unique natural alternative to petroleum-based ingredients. Natunola offers its customers vegetable gels based on canola, sunflower, castor and rice bran oils, as well as customized ingredients.
About Kiwa Bio-Tech Products Group Corporation
The Company develops, manufactures, distributes and markets innovative, cost-effective, and environmentally safe bio-technological products for agricultural and natural resources and environmental conservation. The Company has acquired the rights to manufacture and market AF-01 Anti-viral Aerosol Agent for use in preventing (blocking) bird-flu disease in Chinese and international markets. The Company has excellent relations with government authorities in China and has developed several innovative, high margin products, while continuing to grow through internal and external product development. The Company's products are designed to enhance the quality of human life by increasing the value, quality and productivity of crops and decreasing the negative environmental impact of chemicals and other wastes. For more information about the Company, please review documents filed with the SEC ( http://www.sec.gov ) or visit the Company's website at http://www.kiwabiotech.com .
This press release contains information that constitutes
forward-looking statements made pursuant to the safe harbor provisions of
the Private Securities Litigation Reform Act of 1995. Any such
forward-looking statements involve risk and uncertainties that could cause
actual results to differ materially from any future results described by
the forward-looking statements. Risk factors that could contribute to such
differences include those matters more fully disclosed in the Company's
reports filed with the Securities and Exchange Commission. The
forward-looking information provided herein represents the Company's
estimates as of the date of the press release, and subsequent events and
developments may cause the Company's estimates to change. The Company
specifically disclaims any obligation to update the forward- looking
information in the future. Therefore, this forward-looking information
should not be relied upon as representing the Company's estimates of its
future financial performance as of any date subsequent to the date of this
For more information, please contact:
Kiwa Bio-Tech Products Group Corporation
|SOURCE Kiwa Bio-Tech Products Group Corporation|
Copyright©2008 PR Newswire.
All rights reserved